2025 Market Access Guide for Biotech: What is essential and what is a waste of resources
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug
Was Sie über vertrauliche Rabatte und Nettopreise in der EU-5 wissen müssen In der EU-5
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part
The Inflation Reduction Act (IRA), signed into law in August 2022, is a piece of
Justin Stindt Consulting ist ein schnell wachsendes Beratungsunternehmen, das Strategie- und Marktzugangsberatungsdienste für führende Kunden aus der Pharma-, Biotech- und Medizintechnikbranche anbietet. Wir sind in Europa und in den Vereinigten Staaten tätig.
